GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 123 filers reported holding GERON CORP in Q1 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $21,000 | +5.0% | 7,624 | -14.2% | 0.00% | – |
| Q1 2017 | $20,000 | +11.1% | 8,888 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | -10.0% | 8,888 | 0.0% | 0.00% | – |
| Q3 2016 | $20,000 | -95.9% | 8,888 | -95.1% | 0.00% | -100.0% |
| Q2 2016 | $482,000 | -90.9% | 179,699 | -90.1% | 0.00% | -92.3% |
| Q1 2016 | $5,325,000 | -19.8% | 1,823,587 | +32.9% | 0.03% | -21.2% |
| Q4 2015 | $6,641,000 | +108.7% | 1,372,147 | +19.0% | 0.03% | +94.1% |
| Q3 2015 | $3,182,000 | -28.7% | 1,152,940 | +10.6% | 0.02% | -22.7% |
| Q2 2015 | $4,463,000 | +19.0% | 1,042,663 | +4.8% | 0.02% | +15.8% |
| Q1 2015 | $3,750,000 | +58.2% | 994,649 | +36.3% | 0.02% | +58.3% |
| Q4 2014 | $2,371,000 | +126.5% | 729,605 | +39.3% | 0.01% | +140.0% |
| Q3 2014 | $1,047,000 | -14.3% | 523,634 | +37.6% | 0.01% | -16.7% |
| Q2 2014 | $1,221,000 | +53.8% | 380,454 | -0.4% | 0.01% | +50.0% |
| Q1 2014 | $794,000 | -52.2% | 381,809 | +9.0% | 0.00% | -50.0% |
| Q4 2013 | $1,660,000 | – | 350,236 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,623,889 | $6,861,000 | 1.25% |
| RA Capital Management | 30,126,299 | $36,754,000 | 0.65% |
| NEA Management Company, LLC | 13,461,538 | $16,423,000 | 0.33% |
| Virtus ETF Advisers LLC | 128,325 | $157,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 227,163 | $277,000 | 0.04% |
| Forefront Analytics, LLC | 84,536 | $103,000 | 0.03% |
| Poehling Capital Management, INC. | 54,000 | $66,000 | 0.02% |
| Summit X, LLC | 71,297 | $86,000 | 0.02% |
| Vishria Bird Financial Group, LLC | 20,615 | $25,000 | 0.01% |
| Piscataqua Savings Bank | 12,500 | $15,000 | 0.01% |